| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.7927 | 
      | Human Intestinal Absorption | HIA+ | 0.9892 | 
      | Caco-2 Permeability | Caco2- | 0.6157 | 
      | P-glycoprotein Substrate | Non-substrate | 0.6453 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.5185 | 
                                                     | Non-inhibitor | 0.7509 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.6957 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4653 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.6516 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8178 | 
      | CYP450 3A4 Substrate | Substrate | 0.5243 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.5153 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.5078 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8897 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.5140 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.6157 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5638 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6503 | 
                                                                    | Non-inhibitor | 0.5704 | 
      | AMES Toxicity | Non AMES toxic | 0.6181 | 
      | Carcinogens | Non-carcinogens | 0.8573 | 
      | Fish Toxicity | High FHMT | 0.5595 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7002 | 
      | Honey Bee Toxicity | Low HBT | 0.7440 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.7910 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5205 |